Literature DB >> 20457143

Plasma metabolic profiling of Alzheimer's disease by liquid chromatography/mass spectrometry.

Nai-jing Li1, Wen-tao Liu, Wei Li, Sheng-qi Li, Xiao-hui Chen, Kai-shun Bi, Ping He.   

Abstract

OBJECTIVES: The identification of Alzheimer's disease (AD) biomarkers may allow for a less invasive and more accurate diagnosis as well as serve as a predictor of future disease progression and treatment response. The aim of this study was to map potential biomarkers in plasma for AD. DESIGN AND METHODS: Plasma metabolic perturbations between AD and healthy old person were investigated using ultra performance liquid chromatography/mass spectrometry (UPLC/MS) and metabonomics approach. The principal component analysis (PCA) of UPLC/MS spectra showed that metabolic changes between two groups.
RESULTS: The PCA of UPLC/MS spectra showed that metabolic changes observed between AD and control were clear. Nine potential biomarkers in correlation with the extent of AD were found.
CONCLUSIONS: Based on PCA, several potential biomarkers (LPCs, sphingosine and tryptophan) were found and further identified by the following LC/MS/MS analysis. All of them could be the potential early markers of AD. 2010. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20457143     DOI: 10.1016/j.clinbiochem.2010.04.072

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  22 in total

1.  Understanding the cholesterol metabolism-perturbing effects of docosahexaenoic acid by gas chromatography-mass spectrometry targeted metabonomic profiling.

Authors:  Priti Bahety; Thi Hai Van Nguyen; Yanjun Hong; Luqi Zhang; Eric Chun Yong Chan; Pui Lai Rachel Ee
Journal:  Eur J Nutr       Date:  2015-10-01       Impact factor: 5.614

Review 2.  Metabolomics: a novel approach to identify potential diagnostic biomarkers and pathogenesis in Alzheimer's disease.

Authors:  Xu-Hua Xu; Yue Huang; Gang Wang; Sheng-Di Chen
Journal:  Neurosci Bull       Date:  2012-10-03       Impact factor: 5.203

3.  Endogenous N-acyl taurines regulate skin wound healing.

Authors:  Oscar Sasso; Silvia Pontis; Andrea Armirotti; Giorgia Cardinali; Daniela Kovacs; Marco Migliore; Maria Summa; Guillermo Moreno-Sanz; Mauro Picardo; Daniele Piomelli
Journal:  Proc Natl Acad Sci U S A       Date:  2016-07-13       Impact factor: 11.205

4.  What success can teach us about failure: the plasma metabolome of older adults with superior memory and lessons for Alzheimer's disease.

Authors:  Mark Mapstone; Feng Lin; Mike A Nalls; Amrita K Cheema; Andrew B Singleton; Massimo S Fiandaca; Howard J Federoff
Journal:  Neurobiol Aging       Date:  2016-11-21       Impact factor: 4.673

5.  Targeted Lipidomics To Measure Phospholipids and Sphingomyelins in Plasma: A Pilot Study To Understand the Impact of Race/Ethnicity in Alzheimer's Disease.

Authors:  Mostafa J Khan; Nadjali A Chung; Shania Hansen; Logan Dumitrescu; Timothy J Hohman; M Ilyas Kamboh; Oscar L Lopez; Renã A S Robinson
Journal:  Anal Chem       Date:  2022-03-02       Impact factor: 8.008

Review 6.  Biomarkers in Alzheimer's disease analysis by mass spectrometry-based proteomics.

Authors:  Yahui Liu; Hong Qing; Yulin Deng
Journal:  Int J Mol Sci       Date:  2014-05-06       Impact factor: 5.923

7.  Biomarker Discovery and Translation in Metabolomics.

Authors:  G A Nagana Gowda; D Raftery
Journal:  Curr Metabolomics       Date:  2013

8.  Perspective: The Potential Role of Circulating Lysophosphatidylcholine in Neuroprotection against Alzheimer Disease.

Authors:  Richard D Semba
Journal:  Adv Nutr       Date:  2020-07-01       Impact factor: 8.701

9.  Lipidomics of Alzheimer's disease: current status.

Authors:  Paul L Wood
Journal:  Alzheimers Res Ther       Date:  2012-02-01       Impact factor: 6.982

10.  The Molecular Mechanism of Amyloid β42 Peptide Toxicity: The Role of Sphingosine Kinase-1 and Mitochondrial Sirtuins.

Authors:  Magdalena Cieślik; Grzegorz A Czapski; Joanna B Strosznajder
Journal:  PLoS One       Date:  2015-09-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.